H. Lepor

Christopher U. Jones, K. Pienta, H. Sandler, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

How Active is Active Surveillance ? Intensity of Follow-Up During Active Surveillance for Prostate Cancer in the United States Running Title : Intensity of Prostate Cancer Active Surveillance

H. Lepor, D. Makarov, S. Loeb, 2016 .

How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States.

H. Lepor, D. Makarov, S. Loeb, 2016, The Journal of urology.

Is sildenafil failure in men after radical retropubic prostatectomy (RRP) due to arterial disease? Penile duplex Doppler findings in 174 men after RRP

H. Lepor, A. McCullough, K. Woo, 2002, International Journal of Impotence Research.

Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.

H. Lepor, G. Godoy, L. Glickman, 2009, The Journal of urology.

Time to return to work and physical activity following open radical retropubic prostatectomy.

H. Lepor, Denisa Slova, R. Sultan, 2006, The Journal of urology.

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation

S. Taneja, H. Lepor, A. Katz, 2021, Advances in Radiation Oncology.

Testosterone Deficiency and the Prostate.

H. Lepor, J. Alukal, 2016, The Urologic clinics of North America.

Management of High-Grade Prostatic Intraepithelial Neoplasia (HGPIN)

S. Taneja, H. Lepor, Krishna Ramaswamy, 2013 .

Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies.

H. Lepor, E. Shapiro, T. Opgenorth, 1993, The Journal of urology.

Minimally invasive ablative therapies for the treatment of prostate cancer.

H. Lepor, 2011, Reviews in urology.

A Prospective Pilot Study Investigating Performance of 18F-Fluciclovine PET Imaging for Detection of Prostate Cancer 2 Years Following Primary Partial Gland Cryoablation

S. Taneja, H. Lepor, William C. Huang, 2022, Nuclear medicine and molecular imaging.

Platinum Priority – Prostate Cancer Editorial by Thorsten Schlomm and Meike Adam on pp . 66 – 67 of this issue Ten-year Outcomes of Sexual Function After Radical Prostatectomy : Results of a Prospective Longitudinal Study

V. Prabhu, H. Lepor, Glen B. Taksler, 2013 .

The role of radical prostatectomy in the management of prostatic cancer

P. Walsh, H. Lepor, 1987, Cancer.

Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism.

Kun Xu, H. Lepor, E. Shapiro, 2011, Developmental biology.

LEF1 identifies androgen-independent epithelium in the developing prostate.

Kun Xu, J. Melamed, H. Lepor, 2011, Molecular endocrinology.

Radical retropubic prostatectomy. Preoperative management.

H. Lepor, N. Rosenblum, Herbert Lepor, 2001, The Urologic clinics of North America.

Practical considerations in radical retropubic prostatectomy.

H. Lepor, 2003, The Urologic clinics of North America.

Selecting treatment for high-risk, localized prostate cancer: the case for radical prostatectomy.

H. Lepor, 2002, Reviews in urology.

The Use of Pharmacologic Agents for Benign Prostatic Hyperplasia

H. Lepor, C. Dixon, 1994 .

Terazosin in the treatment of benign prostatic hyperplasia: the United States experience.

H. Lepor, A. Laddu, 1992, British journal of urology.

The emerging role of alpha antagonists in the therapy of benign prostatic hyperplasia.

H. Lepor, 1991, Journal of andrology.

Factors predisposing to the development of anastomotic strictures in a single‐surgeon series of radical retropubic prostatectomies

H. Lepor, George J. Huang, 2006, BJU international.

Risk Stratification by Urinary Prostate Cancer Gene 3 Testing Before Magnetic Resonance Imaging-Ultrasound Fusion-targeted Prostate Biopsy Among Men With No History of Biopsy.

A. Rosenkrantz, S. Taneja, F. Deng, 2017, Urology.

Is Targeted Therapy of Prostate Cancer Ready for Prime Time?

H. Lepor, 2016, European urology.

MP67-14 PREDICTIVE VALUE OF NEGATIVE 3T MULTIPARAMETRIC PROSTATE MRI ON 12 CORE BIOPSY RESULTS

M. Stifelman, A. Rosenkrantz, S. Taneja, 2014 .

Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial.

T. Stamey, D. Chan, A. Partin, 2003, The Journal of urology.

Long-term, open-label, phase III multicenter study of tamsulosin in benign prostatic hyperplasia.

H. Lepor, P. Narayan, P. Narayan, 2001, Urology.

Prostatic alpha 1-adrenoceptors and uroselectivity.

H. Lepor, K. Andersson, M. Wyllie, 1997, The Prostate.

of its kidney-specific activity in transgenic mice Isolation of mouse THP gene promoter and demonstration

H. Lepor, Jin Cheng, J. Pak, 2016 .

Isolation of mouse THP gene promoter and demonstration of its kidney-specific activity in transgenic mice.

H. Lepor, Jin Cheng, J. Pak, 2002, American journal of physiology. Renal physiology.

Transforming growth factor‐β is an autocrine mitogen for a novel androgen‐responsive murine prostatic smooth muscle cell line, PSMC1

T. Sun, H. Lepor, E. Shapiro, 2000, Journal of cellular physiology.

A comparison of the urological complications associated with long-term management of quadriplegics with and without chronic indwelling urinary catheters.

H. Lepor, G. Anderson, M. Gottlieb, 1992, The Journal of urology.

Muscarinic Cholinergic Receptors in Bladder Exstrophy

H. Lepor, E. Shapiro, J. Gearhart, 1999 .

Mitogenic activation of human prostate‐derived fibromuscular stromal cells by bradykinin

H. Lepor, M. Ittmann, P. Walden, 1999, British journal of pharmacology.

Endothelin‐1 production and agonist activities in cultured prostate‐derived cells: Implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia

H. Lepor, M. Ittmann, P. Walden, 1998, The Prostate.

Evaluation of the effect of endothelin-1 and characterization of the selective endothelin a receptor antagonist PD155080 in the prostate.

H. Lepor, A. Doherty, E. Shapiro, 1997, The Journal of urology.

Smooth muscle development in the obstructed fetal bladder.

H. Lepor, E. Shapiro, A. Freedman, 1997, Urology.

Alpha blockers for the treatment of benign prostatic hyperplasia.

H. Lepor, 2007, Reviews in urology.

Pathophysiology of benign prostatic hyperplasia in the aging male population.

H. Lepor, 2005, Reviews in urology.

The pathophysiology of lower urinary tract symptoms in the ageing male population.

H. Lepor, 1998, British journal of urology.

Morphometric analysis of pediatric and nonhyperplastic prostate glands: Evidence that BPH is not a unique stromal process

H. Lepor, E. Shapiro, E. Perlman, 1997, The Prostate.

Comparison of alpha1 Adrenoceptors in the Prostate Capsule of Men with Symptomatic and Asymptomatic Benign Prostatic Hyperplasia

H. Lepor, E. Shapiro, M. Baumann, 1991 .

Determination of norepinephrine levels in the adult human prostate.

H. Lepor, E. Shapiro, R. Bowsher, 1990, The Journal of urology.

Contractile properties of human prostate adenomas and the development of infravesical obstruction

H. Lepor, E. Shapiro, M. Baumann, 1989, The Prostate.

Medical Treatment of Benign Prostatic Hyperplasia

H. Lepor, 1988, The Lancet.

Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia.

H. Lepor, 2004, Reviews in urology.

Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.

H. Lepor, T. Chun, S. Martin, 1998, Urology.

Short-, Intermediate-, and Long-term Quality of Life Outcomes Following Radical Prostatectomy for Clinically Localized Prostate Cancer.

Tyler R. McClintock, V. Prabhu, H. Lepor, 2013, Reviews in urology.

Does a nerve‐sparing technique or potency affect continence after open radical retropubic prostatectomy?

H. Lepor, T. Marien, Tracy P. Marien, 2008, BJU international.

Reoperation versus observation in men with major bleeding after radical retropubic prostatectomy.

H. Lepor, Jeremy D Kaufman, 2005, Urology.

Outcomes for men younger than 50 years undergoing radical prostatectomy.

H. Lepor, Denisa Slova, C. Twiss, 2005, Urology.

The impact of open radical retropubic prostatectomy on continence and lower urinary tract symptoms: a prospective assessment using validated self-administered outcome instruments.

H. Lepor, L. Kaçi, Herbert Lepor, 2004, The Journal of urology.

Selecting candidates for radical prostatectomy.

H. Lepor, 2000, Reviews in urology.

Ten-year outcomes of sexual function after radical prostatectomy: results of a prospective longitudinal study.

V. Prabhu, H. Lepor, Glen B. Taksler, 2014, European urology.

Comparison of health‐related quality‐of‐life outcomes for African‐American and Caucasian‐American men after radical prostatectomy

H. Lepor, I. Agalliu, T. Marien, 2012, BJU international.

Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy.

H. Lepor, A. Sankin, T. Marien, 2008, The Journal of urology.

Long‐Term Continence Outcomes in Men Undergoing Radical Prostatectomy: A Prospective 15‐Year Longitudinal Study

Elton Llukani, H. Lepor, Glen B. Taksler, 2018, The Journal of urology.

Radical Prostatectomy: Status and Opportunities for Improving Outcomes

H. Lepor, 2004, Cancer investigation.

Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms.

H. Lepor, E. J. Schwartz, Herbert Lepor, 1999, The Journal of urology.

Perianastomotic injection of autologous fat at the time of radical retropubic prostatectomy.

H. Lepor, C. Dixon, M. Guerena, 1994, Urology.

Benign prostatic hyperplasia: current clinical practice.

H. Lepor, B. Djavan, E. Eckersberger, 2010, Primary care.

The role of bladder neck biopsy in men undergoing radical retropubic prostatectomy with preservation of the bladder neck.

J. Melamed, H. Lepor, S. Chan, 1998, The Journal of urology.

Controversies old and new

H. Lepor, V. Nitti, 1995, The Lancet.

Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.

M. Kutner, H. Lepor, W. Williford, 2003, The Journal of urology.

Endothelins in canine genitourinary tissues.

H. Lepor, E. Shapiro, T. Opgenorth, 1997, The Journal of urology.

Alpha blockade for the treatment of benign prostatic hyperplasia.

H. Lepor, Herbert Lepor, 1995, The Urologic clinics of North America.

The pathophysiology of clinical BPH.

H. Lepor, E. Shapiro, 1994, Progress in clinical and biological research.

Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?

T. Stamey, D. Chan, A. Partin, 2002, Urology.

Axumin (18F-Fluciclovine) PET imaging in men exhibiting no clinically significant cancer on initial negative biopsy of PI-RADS 4 and 5 regions of interest

S. Taneja, H. Lepor, William C. Huang, 2022, World Journal of Urology.

A prospective study of cancer detection rates following early repeat imaging and biopsy of PI-RADS 4 and 5 regions of interest exhibiting no clinically significant prostate cancer on prior biopsy.

S. Taneja, H. Lepor, William C. Huang, 2022, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group.

H. Lepor, 1998, Urology.

Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: a multi-institutional evaluation by experienced surgeons.

W. Catalona, P. Walsh, H. Lepor, 2001, Urology.

Neurovascular bundle resection: does it improve the margins?

H. Lepor, B. Tareen, Basir U. Tareen, 2010, Urologic oncology.

SSI Prize Essay for Male Erectile Dysfunction—Clinical ‘Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nerve-sparing radical retropubic prostatectomy (RRP)’

H. Lepor, A. McCullough, E. Hong, 1999, International Journal of Impotence Research.

Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: a detailed anatomical study of the adult male pelvis.

P. Walsh, F. Mostofi, H. Lepor, 1985, The Journal of urology.

Surgical Treatment of Prostate Carcinoma.

H. Lepor, 2017, The Journal of urology.

The role of radical prostatectomy in the treatment of cancer of the prostate.

H. Lepor, 1989, Cancer treatment and research.

Insights into the natural history and treatment of benign prostatic hyperplasia.

H. Lepor, 2006, The Journal of urology.

Landmark studies impacting the medical management of benign prostatic hyperplasia.

H. Lepor, 2003, Reviews in urology.

The short-term and long-term effects of radical prostatectomy on lower urinary tract symptoms.

H. Lepor, Denisa Slova, 2007, The Journal of urology.

Primary aldosteronism caused by unilateral adrenal hyperplasia.

J. Melamed, H. Lepor, J. Waisman, 2000, Reviews in urology.

Managing and preventing acute urinary retention.

H. Lepor, 2005, Reviews in urology.

An artificial somatic-autonomic reflex pathway procedure for bladder control in children with spina bifida.

H. Lepor, E. Shapiro, P. Cheng, 2005, The Journal of urology.

The prostatic utricle is not a Müllerian duct remnant: immunohistochemical evidence for a distinct urogenital sinus origin.

H. Lepor, Hong-ying Huang, E. Shapiro, 2004, The Journal of urology.

Review ArticleIdiopathic Retroperitoneal Fibrosis

H. Lepor, Patrick C. Walshi, 1979 .

Expression of the ETA and ETB Endothelin Receptor Subtype mRNA in Human Detrusor Cultured Smooth Muscle Cells

H. Lepor, Y. Tomita, P. Walden, 2000, Urologia Internationalis.

Localization of endothelin receptors in the human prostate.

H. Lepor, E. Shapiro, S. Kobayashi, 1994, The Journal of urology.

Bladder wall abnormalities in myelodysplastic bladders: a computer assisted morphometric analysis.

M. Becich, H. Lepor, E. Shapiro, 1991, The Journal of urology.

Alpha 2 adrenergic receptors in hyperplastic human prostate: identification and characterization using [3H] rauwolscine.

H. Lepor, E. Shapiro, 1986, The Journal of urology.

Muscarinic cholinergic receptors in bladder exstrophy: insights into surgical management.

H. Lepor, E. Shapiro, J. Gearhart, 1985, The Journal of urology.

Down regulation of the muscarinic cholinergic receptor of the rat prostate following castration.

H. Lepor, E. Shapiro, A. Miller, 1985, The Journal of urology.

Comparison of single-agent androgen suppression for advanced prostate cancer.

H. Lepor, 2005, Reviews in urology.

Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study.

H. Lepor, L. Hill, J. Nickel, 2011, The Journal of urology.

2 Year Functional Outcomes Stratified According to Baseline Erectile Function Following Partial Gland Cryo-Ablation.

H. Lepor, E. Rapoport, S. Thakker, 2022, Urology.

Effects of nitric oxide on human and canine prostates.

H. Lepor, A. Burnett, E. Shapiro, 1995, Urology.

Partial gland cryoablation for prostate cancer — where are we?

H. Lepor, Wei Phin Tan, James S. Wysock, 2022, Nature Reviews Urology.

Historical Overview of Medical Therapy for Benign Prostatic Hyperplasia

C. Roehrborn, H. Lepor, 2005 .

Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015

H. Lepor, D. Makarov, S. Loeb, 2018, JAMA.

A Prospective Pilot Study Investigating Performance of 18F-Fluciclovine PET Imaging for Detection of Prostate Cancer 2 Years Following Primary Partial Gland Cryoablation

S. Taneja, H. Lepor, William C. Huang, 2022, Nuclear Medicine and Molecular Imaging.

The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia.

C. Roehrborn, H. Lepor, J. Kusek, 2007, The Journal of urology.

Aetiology and management of earlier vs later biochemical recurrence after retropubic radical prostatectomy

Elton Llukani, H. Lepor, 2017, BJU international.

Long-term Natural History of Lower Urinary Tract Symptoms Following Radical Retropubic Prostatectomy: A Prospective 15-Year Longitudinal Study.

Elton Llukani, H. Lepor, Glen B. Taksler, 2018, Urology.

Does open radical retropubic prostatectomy decrease the risk of acute urinary retention?

H. Lepor, G. Godoy, B. Tareen, 2008, Urology.

Prostatic Diseases and Male Voiding Dysfunction Does Open Radical Retropubic Prostatectomy Decrease the Risk of Acute Urinary Retention

H. Lepor, G. Godoy, B. Tareen, 2008 .

Spontaneous retroperitoneal hemorrhage caused by segmental arterial mediolysis.

H. Lepor, C. Phillips, 2006, Reviews in urology.

Lap pak for abdominal retraction.

Sam S. Chang, H. Lepor, G. Steinberg, 2012, Reviews in urology.

Prostatic intraepithelial neoplasia in a 53-year-old man.

H. Lepor, 2005, Reviews in urology.

The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism.

H. Lepor, H Lepor, G. Rigaud, 1990, The Journal of urology.

Transperineal Sonocystography

H. Lepor, S. Telegrafi, J. Laze, 2010, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Transabdominal sonocystography: a novel technique to assess vesicourethral extravasation following radical prostatectomy.

H. Lepor, S. Telegrafi, J. Laze, 2008, The Journal of urology.

Postoperative blood loss predicts the development of urinary extravasation on cystogram following radical retropubic prostatectomy.

H. Lepor, Denisa Slova, D. Fenig, 2006, The Journal of urology.

Removal of urinary catheter on postoperative day 3 or 4 after radical retropubic prostatectomy.

H. Lepor, Rupa Patel, 2003, Urology.

Characterization and localization of nitric oxide synthase in the human prostate.

H. Lepor, M. Takeda, A. Burnett, 1995, Urology.

Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience.

Ted Lee, Dan Sperling, Herbert Lepor, 2014, Reviews in urology.

Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate.

H. Lepor, P. Walden, C. Gerardi, 1999, The Journal of urology.

Comparison of alpha 1 adrenoceptors in the prostate capsule of men with symptomatic and asymptomatic benign prostatic hyperplasia.

H. Lepor, E. Shapiro, M. Baumann, 1991, British journal of urology.

Evaluation and Nonsurgical Management of Benign Prostatic Hyperplasia

H. Lepor, R. Kirby, T. McNicholas, 2012 .

Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology.

Lori J Sokoll, David H Wilson, Alan W Partin, 2011, Clinical chemistry.

Skin preparation for the prevention of surgical site infection: which agent is best?

H. Lepor, M. Hemani, 2009, Reviews in urology.

Acrolein- and 4-Aminobiphenyl-DNA adducts in human bladder mucosa and tumor tissue and their mutagenicity in human urothelial cells

Nicholas M. Donin, H. Lepor, M. Tang, 2014, Oncotarget.

The role of TAp63γ and P53 point mutations in regulating DNA repair, mutational susceptibility and invasion of bladder cancer cells

H. Lepor, M. Tang, William C. Huang, 2021, eLife.

Prostate adenocarcinoma presenting as a large supraclavicular mass.

H. Lepor, R. Wieczorek, P. Torre, 2001, Reviews in urology.

A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.

B Stein, J. Kabalin, H. Lepor, 1995, Urology.

Role of intraoperative biopsies during radical retropubic prostatectomy.

Herbert Lepor, H. Lepor, Ledia Kaci, 2004, Urology.

Matrix changes in the bladder associated with normal aging.

H. Lepor, E. Shapiro, 1995, Advances in experimental medicine and biology.

Gene polymorphisms and prostate cancer: the evidence

R. Herwig, H. Lepor, B. Djavan, 2009, BJU international.

Alpha 1 adrenergic receptors in canine lower genitourinary tissues: insight into development and function.

H. Lepor, E. Shapiro, 1987, The Journal of urology.

Altered smooth muscle development and innervation in the lower genitourinary and gastrointestinal tract of the male human fetus with myelomeningocele.

G. Hutchins, H. Lepor, E. Shapiro, 1998, The Journal of urology.

Cause-specific actuarial survival analysis: a useful method for reporting survival data in men with clinically localized carcinoma of the prostate.

P. Walsh, H. Lepor, A. Kimball, 1989, The Journal of urology.

Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

M. Barry, H. Lepor, Yuchiao Chang, 1995, The Journal of urology.

Gleason 6 prostate cancer: serious malignancy or toothless lion?

Herbert Lepor, Nicholas M. Donin, H. Lepor, 2014, Oncology.

PKM2 is essential for bladder cancer growth and maintenance.

Yan Liu, T. Sun, H. Lepor, 2021, Cancer research.

Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.

C. Cordon-Cardo, T. Sun, H. Lepor, 2007, The Journal of clinical investigation.

Phosphorylation of the Androgen Receptor by PIM1 in Hormone Refractory Prostate Cancer

W. Gerald, J. Melamed, S. Taneja, 2012, Oncogene.

Focal Therapy of Prostate Cancer by Radiofrequency and Photodynamic Therapy

H. Lepor, B. Djavan, Reza Zare, 2013 .

Prostate-specific antigen testing and prostate cancer screening.

S. Taneja, H. Lepor, B. Djavan, 2010, Primary care.

Vascular targeted photodynamic therapy for localized prostate cancer.

Herbert Lepor, H. Lepor, 2008, Reviews in urology.

Utility of Single-Cell Genomics in Diagnostic Evaluation of Prostate Cancer.

A. Krasnitz, J. Kendall, M. Wigler, 2018, Cancer research.

Uroplakins play conserved roles in egg fertilization and acquired additional urothelial functions during mammalian divergence

R. DeSalle, T. Sun, F. Deng, 2018, Molecular biology of the cell.

Cigarette side-stream smoke lung and bladder carcinogenesis: inducing mutagenic acrolein-DNA adducts, inhibiting DNA repair and enhancing anchorage-independent-growth cell transformation

W. Rom, H. Lepor, M. Tang, 2015, Oncotarget.

Aldehydes are the predominant forces inducing DNA damage and inhibiting DNA repair in tobacco smoke carcinogenesis

W. Rom, H. Lepor, M. Tang, 2018, Proceedings of the National Academy of Sciences.

Characterization of muscarinic cholinergic receptor binding in the vas deferens, bladder, prostate and penis of the rabbit.

H. Lepor, M. Kuhar, 1984, The Journal of urology.

Copolymerization of single-cell nucleic acids into balls of acrylamide gel

A. Krasnitz, J. Kendall, M. Wigler, 2019, Genome research.

Proximal Prostatic Stem Cells Are Programmed to Regenerate a Proximal‐Distal Ductal Axis

H. Lepor, E. Shapiro, D. Moscatelli, 2006, Stem cells.

Proximal location of mouse prostate epithelial stem cells

T. Sun, H. Lepor, E. Shapiro, 2002, The Journal of cell biology.

Identification of genes associated with stromal hyperplasia and glandular atrophy of the prostate by mRNA differential display.

H. Lepor, P. Walden, J. Gitlin, 1998, Experimental cell research.

Idiopathic retroperitoneal fibrosis.

P. Walsh, H. Lepor, 1979, The Journal of urology.

Innovative surgical management of idiopathic retroperitoneal fibrosis.

H. Lepor, D. Mikkelsen, 1989, The Journal of urology.

The inheritance of the exstrophy-epispadias complex.

H. Lepor, E. Shapiro, R. Jeffs, 1984, The Journal of urology.

Urethral reconstruction in boys with classical bladder exstrophy.

H. Lepor, E. Shapiro, R. Jeffs, 1984, The Journal of urology.

Primary bladder closure and bladder neck reconstruction in classical bladder exstrophy.

H. Lepor, R. Jeffs, 1983, The Journal of urology.

Effects of α-adrenergic agonist on neobladder water and electrolyte transport

H. Lepor, J. Mohler, S. McSherry, 1994 .

Comparison of muscarinic cholinergic and alpha adrenergic receptors in canine ileum, colon, intestinal urinary reservoirs and bladder.

H. Lepor, J. Mohler, E. Shapiro, 1989, The Journal of urology.

Prediction of Prostate Cancer Risk Among Men Undergoing Combined MRI-targeted and Systematic Biopsy Using Novel Pre-biopsy Nomograms That Incorporate MRI Findings.

A. Rosenkrantz, S. Taneja, H. Lepor, 2017, Urology.

Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment.

Andrew B Rosenkrantz, Samir S Taneja, James S Wysock, 2014, The Journal of urology.

Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer.

J. Melamed, H. Lepor, M. Ittman, 1998, The Journal of urology.

Comparison of two different doses of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy.

H. Lepor, A. Nieder, N. Rosenblum, 2001, Urology.

Relationship between prostatc epithelial volume and serum prostate-specific antigen levels

H. Lepor, E. Shapiro, Bo Wang, 1994 .

Relationship between prostatic epithelial volume and serum prostate-specific antigen levels.

H. Lepor, E. Shapiro, B. Wang, 1994, Urology.

Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy.

H. Lepor, A. Sankin, G. Godoy, 2009, Urology.

Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience.

Bob Djavan, Samir S Taneja, Herbert Lepor, 2010, Reviews in urology.

Prostate cancer: radical prostatectomy.

J. Nelson, H. Lepor, 2003, The Urologic clinics of North America.

Contemporary evaluation of operative parameters and complications related to open radical retropubic prostatectomy.

H. Lepor, L. Kaçi, 2003, Urology.

Intraoperative and postoperative complications of radical retropubic prostatectomy in a consecutive series of 1,000 cases.

Michael N. Ferrandino, H. Lepor, A. Nieder, 2001, The Journal of urology.

Pathophysiology of lower urinary tract symptoms in the aging male population.

H. Lepor, 2005, Reviews in urology.

Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202.

D. Grignon, H. Sandler, Q. Zhang, 2013, International journal of radiation oncology, biology, physics.

Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials.

D. Grignon, H. Sandler, B. Donnelly, 2011, International journal of radiation oncology, biology, physics.

Long-Term Evaluation of Tamsulosin in Benign Prostatic Hyperplasia: Placebo-Controlled, Double-Blind Extension of Phase III Trial

H. Lepor, 1998 .

The role of preoperative epoetin alfa in men undergoing radical retropubic prostatectomy.

H. Lepor, M. Levine, N. Rosenblum, 2000, The Journal of urology.

Radical prostatectomy with preservation of sexual function: Anatomical and pathological considerations

Herbert Lepor, P. Walsh, H. Lepor, 1983, The Prostate.

Localization of mRNA and receptor binding sites for the alpha 1a-adrenoceptor subtype in the rat, monkey and human urinary bladder and prostate.

H. Lepor, P. Walden, E. Gustafson, 1997, The Journal of urology.

Localization of the alpha 1A-adrenoceptor in the human prostate.

H. Lepor, E. Shapiro, C. Forray, 1995, The Journal of urology.

Silodosin for the Treatment of Benign Prostatic Hyperplasia: Pharmacology and Cardiovascular Tolerability

H. Lepor, L. Hill, 2010, Pharmacotherapy.

Characterization and localization of prostatic alpha 1 adrenoceptors using radioligand receptor binding on slide-mounted tissue section.

H. Lepor, E. Shapiro, S. Kobayashi, 1993, The Journal of urology.

Alpha 1 adrenoceptor subtypes in the human prostate.

H. Lepor, E. Shapiro, H Lepor, 1993, The Journal of urology.

The alpha‐adrenoceptor subtype mediating the tension of human prostatic smooth muscle

H. Lepor, R. Tang, And Ellen Shapiro, 1993, The Prostate.

Autonomic receptors in human prostate adenomas.

H. Lepor, E. Shapiro, H Lepor, 1990, The Journal of urology.

Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia.

H. Lepor, E. Shapiro, 1984, The Journal of urology.

Characterization and localization of the muscarinic cholinergic receptor in human prostatic tissue.

H. Lepor, M. Kuhar, 1984, The Journal of urology.

Tamsulosin reduces the incidence of acute urinary retention following early removal of the urinary catheter after radical retropubic prostatectomy.

H. Lepor, J. Fiske, Rupa Patel, 2003, Urology.

Testosterone in prostate cancer: the Bethesda consensus

J. Eastham, J. Moul, S. Taneja, 2012, BJU international.

Qualitative study on decision‐making by prostate cancer physicians during active surveillance

A. Fagerlin, H. Lepor, H. Carter, 2017, BJU international.

Can contemporary transrectal prostate biopsy accurately select candidates for hemi‐ablative focal therapy of prostate cancer?

S. Taneja, H. Lepor, A. Sankin, 2009, BJU international.

Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis.

H. Lepor, E. Shapiro, H Lepor, 1992, The Journal of urology.

Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.

I. Mohr, H. Lepor, M. Tang, 2012, Carcinogenesis.

Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH

C. Roehrborn, H. Lepor, S. Kaplan, 2010, Prostate Cancer and Prostatic Diseases.

The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle

H. Lepor, E. Shapiro, V. Hartanto, 1992, The Prostate.

The influence of hormonal therapy on survival of men with advanced prostatic cancer.

P. Walsh, H. Lepor, A. Ross, 1982, The Journal of urology.

Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.

Fang-Ming Deng, Jonathan Melamed, Andrew B Rosenkrantz, 2016, European urology.

Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk Stratification.

A. Rosenkrantz, J. Melamed, S. Taneja, 2015, The Journal of urology.

Multi-parametric MRI imaging of the prostate—implications for focal therapy

H. Lepor, James S. Wysock, 2017, Translational andrology and urology.

Functional Domains of Androgen Receptor Coactivator p44/Mep50/WDR77and Its Interaction with Smad1

Zhengxin Wang, H. Lepor, R. Xu, 2013, PloS one.

Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.

T. Stamey, D. Chan, A. Partin, 2002, Urology.

Diagnostic Strategies for Prostate Cancer

H. Lepor, B. Djavan, A. Farr, 2011 .

Oncological control following partial gland ablation for intermediate-risk prostate cancer.

H. Lepor, E. Becher, 2020, Urologic oncology.

Optimizing patient selection for focal therapy—mapping and ablating the index lesion

H. Lepor, James S. Wysock, 2018, Translational andrology and urology.

Concordance and Performance of 4Kscore® and SelectMDx® for Informing Decision to Perform Prostate Biopsy and Detection of Prostate Cancer.

H. Lepor, S. Loeb, E. Becher, 2020, Urology.

Opening up New Therapeutic Avenues

H. Lepor, James S. Wysock, 2016 .

MP53-11 A PRE-BIOPSY NOMOGRAM FOR PREDICTION OF THE RISK OF GLEASON SCORE = 7 PROSTATE CANCER ON COMBINED MRI-US FUSION TARGETED AND SYSTEMATIC PROSTATE BIOPSY AMONG MEN WITH NO PREVIOUS BIOPSY

A. Rosenkrantz, S. Taneja, H. Lepor, 2016 .

Two-year Outcomes Following Focal Laser Ablation of Localized Prostate Cancer.

Elton Llukani, H. Lepor, Brian Chao, 2018, European urology oncology.

Focal Ablation of Prostate Cancer.

H. Lepor, Herbert Lepor, 2018, Reviews in urology.

The Use of Magnetic Resonance Imaging to Predict Oncological Control Among Candidates for Focal Ablation of Prostate Cancer.

Elton Llukani, J. Melamed, F. Deng, 2018, Urology.

Early oncological control following partial gland cryo-ablation: a prospective experience specifying reflex MRI guided biopsy of the ablation zone

H. Lepor, Nermarie Velázquez, E. Becher, 2020, Prostate Cancer and Prostatic Diseases.

Focal Ablation of Prostate Cancer.

H. Lepor, Samuel Gold, James S. Wysock, 2018, Reviews in urology.

Site of positive surgical margins influences biochemical recurrence after radical prostatectomy

H. Lepor, G. Godoy, B. Tareen, 2009, BJU international.

Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy

H. Lepor, A. Sankin, B. Tareen, 2009, Prostate Cancer and Prostatic Diseases.

Natural History of Pathologically Benign Cancer Suspicious Regions on Multiparametric Magnetic Resonance Imaging Following Targeted Biopsy.

Elton Llukani, H. Lepor, W. Huang, 2015, The Journal of urology.

Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.

T. Stamey, D. Chan, A. Partin, 2003, Urology.

Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection.

S. Taneja, H. Lepor, K. Tran, 2001, Urology.

Laterality alone should not drive selection of candidates for hemi-ablative focal therapy.

S. Taneja, H. Lepor, A. Sankin, 2009, The Journal of urology.

Oncologic, Functional, and Cost Analysis of Open, Laparoscopic, and Robotic Radical Prostatectomy

H. Lepor, B. Djavan, E. Eckersberger, 2010 .

A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy.

M. Stifelman, J. Babb, A. Rosenkrantz, 2016, Urologic oncology.

Pathophysiology of clinical benign prostatic hyperplasia.

H. Lepor, E. Shapiro, 1995, The Urologic clinics of North America.

Comparison of the cellular composition of benign prostatic hyperplasia in Chinese and Caucasian-American men.

H. Lepor, E. Shapiro, B. Wang, 1996, Urology.

Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.

Samir S Taneja, Herbert Lepor, S. Taneja, 2005, The Journal of urology.

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.

H. Lepor, M. Brawer, P. Narayan, 1996, The New England journal of medicine.

Alpha 2 adrenergic receptors in canine prostate: biochemical and functional correlations.

H. Lepor, E. Shapiro, J. Tsitlik, 1987, The Journal of urology.

Medical therapy for benign prostatic hyperplasia.

H. Lepor, 1993, Urology.

Prostatic alpha adrenoceptors.

H. Lepor, E. Shapiro, 1994, Progress in clinical and biological research.

The α-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate

H. Lepor, P. Walden, A. Hatano, 1996 .

Binding and functional properties of alpha 1 adrenoceptors and area density of smooth muscle in the canine prostate.

H. Lepor, E. Shapiro, S. Meretyk, 1992, The Journal of urology.

The alpha adrenergic binding properties of terazosin in the human prostate adenoma and canine brain.

H. Lepor, E. Shapiro, M. Baumann, 1988, The Journal of urology.

The effect of electrocautery on neurotransmitter receptor binding assays in the canine prostate.

H. Lepor, E. Shapiro, M. Baumann, 1988, The Journal of urology.

Benign prostatic hyperplasia: Preface

H. Lepor, P. Walsh, 1990 .

Decreased prostatic secretory function in canine benign prostatic hyperplasia is not due to decreased levels of muscarinic cholinergic receptors.

H. Lepor, S. Berry, 1984, Journal of Urology.

A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia.

H. Lepor, P. Narayan, M. Soloway, 1992, The Journal of urology.

Nonoperative management of benign prostatic hyperplasia.

H. Lepor, H Lepor, 1989, The Journal of urology.

Identification and characterization of alpha 1 adrenergic receptors in the canine prostate using [125I]-Heat.

H. Lepor, E. Shapiro, M. Baumann, 1987, The Journal of urology.

1132: Creation of a Somatic-Autonomic Reflex Pathway for Treatment of Neurogenic Bladder in Patients with Spinal Cord Injury: Preliminary Results of First 2 USA Patients

H. Lepor, V. Nitti, A. Berić, 2005 .

Muscarinic cholinergic receptors in normal pediatric and myelodysplastic bladders.

H. Lepor, E. Shapiro, M. Baumann, 1989, The Journal of urology.

Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.

U. Siebert, N. Mühlberger, H. Lepor, 2017, European urology.

Anatomic considerations of the penis and its lymphatic drainage.

H. Lepor, D. Dewire, 1992, The Urologic clinics of North America.

E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells

H. Lepor, M. Tang, William C. Huang, 2018, Proceedings of the National Academy of Sciences.

Electronic-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice

A. Moreira, F. Deng, H. Lepor, 2019, Proceedings of the National Academy of Sciences.

Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.

J. Melamed, S. Taneja, H. Lepor, 2013, JAMA.

Influence of body weight and prostate volume on intraoperative, perioperative, and postoperative outcomes after radical retropubic prostatectomy.

H. Lepor, E. Hsu, E. Hong, 2003, Urology.

Inguinal hernias in men undergoing open radical retropubic prostatectomy.

H. Lepor, D. Robbins, 2007, Urology.

Comprehensive preoperative evaluation and repair of inguinal hernias at the time of open radical retropubic prostatectomy decreases risk of developing post‐prostatectomy hernia

J. Babb, B. Taouli, H. Lepor, 2012, BJU International.

Optimizing the detection of subclinical inguinal hernias in men undergoing open radical retropubic prostatectomy

J. Babb, B. Taouli, H. Lepor, 2010, BJU international.

Adult Urology Inguinal Hernias in Men Undergoing Open Radical Retropubic Prostatectomy

H. Lepor, D. Robbins, 2007 .

Risk of Small Bowel Obstruction After Robot-Assisted vs Open Radical Prostatectomy.

A. Kibel, H. Lepor, C. Meyer, 2016, Journal of endourology.

A review of surgical techniques for radical prostatectomy.

H. Lepor, 2005, Reviews in urology.

Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence.

H. Lepor, J. Goldberg, R. Park, 2001, Urology.

Early removal of urinary catheter after radical retropubic prostatectomy is both feasible and desirable.

H. Lepor, A. Nieder, M. Fraiman, 2001, Urology.

Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359

Karen Spärck Jones, H. Lepor, M. Brawer, 1999, The Prostate.

Filling and voiding symptoms in the American Urological Association symptom index: the value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia.

M. Barry, H. Lepor, W. Williford, 2000, The Journal of urology.

The Role of Minimally Invasive Surgical Techniques in the Management of Large-gland Benign Prostatic Hypertrophy.

J. Lingeman, H. Lepor, O. Shah, 2015, Reviews in urology.

Evaluating men with benign prostatic hyperplasia.

H. Lepor, 2004, Reviews in urology.

Blood loss during radical prostatectomy: impact on clinical, oncological and functional outcomes and complication rates

H. Lepor, I. Agalliu, B. Djavan, 2012, BJU international.

Single‐cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile

J. Melamed, S. Taneja, F. Deng, 2023, The Prostate.

The role of gonadotropin-releasing hormone antagonists for the treatment of benign prostatic hyperplasia.

Herbert Lepor, H. Lepor, 2006, Reviews in urology.

Predicting continence following radical prostatectomy

H. Lepor, David W. Marsh, 2001, Current urology reports.

Alpha blockade in the therapy of benign prostatic hyperplasia

H. Lepor, 1993 .

α-Adrenergic Blockade in the Treatment of Benign Prostatic Hyperplasia

H. Lepor, F. Lowe, 1993 .

A dose titration study evaluating terazosin, a selective, once-a-day alpha 1-blocker for the treatment of symptomatic benign prostatic hyperplasia.

H. Lepor, H. Sunshine, G. Knapp-Maloney, 1990, The Journal of urology.

The efficacy and safety of terazosin for the treatment of symptomatic BPH

H. Lepor, A. Laddu, D. Henry, 1991, The Prostate.

Guidelines for Reporting Studies of Treatment for Prostatic Cancer

D. Byar, R. Simon, H. Lepor, 1988 .

Predicting cancer on repeat biopsy: Results of a multicenter prospective evaluation of complexed PSA

D. Chan, A. Partin, L. Sokoll, 2003 .

Benign prostatic hyperplasia.

H. Lepor, 1995, The Journal of urology.

Benign Prostatic Obstruction Relief in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Enlargement Undergoing Endoscopic Surgical Procedures or Therapy with Alpha-Blockers: A Review of Urodynamic Studies

H. Lepor, N. Longo, M. Creta, 2017, Advances in Therapy.

The effect of surgical intervention for stress urinary incontinence (UI) on post‐prostatectomy UI during sexual activity

H. Lepor, R. Jain, J. Laze, 2012, BJU international.

Quantifying the Smooth Muscle Content of the Prostate Using Double Immunoenzymatic Staining and Color-Assisted Image Analysis

Ellen Shapiro, Herbert Lepor, H. Lepor, 1992 .

Transrectal ultrasonography in the diagnosis and staging of carcinoma of the prostate.

L. Kavoussi, W. Catalona, G. Andriole, 1988, The Journal of urology.

Is the apical soft tissue margin a better predictor of biochemical recurrence than the surgical specimen?

H. Lepor, G. Godoy, B. Tareen, 2011, Urologic oncology.

IS THE APICAL SOFT TISSUE MARGIN (ASTM) A BETTER PREDICTOR OF BIOCHEMICAL RECURRENCE (BR) THAN THE SURGICAL SPECIMEN MARGIN

H. Lepor, G. Godoy, B. Tareen, 2008 .

5-Year Outcomes Following Focal Laser Ablation of Prostate Cancer.

H. Lepor, Brian W Chao, 2021, Urology.

Pathophysiology of benign prostatic hyperplasia: insights from medical therapy for the disease.

H. Lepor, 2009, Reviews in urology.

A dose-response study of the effect of flutamide on benign prostatic hyperplasia: results of a multicenter study.

F M Debruyne, P. Schellhammer, A. Tewari, 1996, Urology.

The relative efficacy of terazosin versus terazosin and flutamide for the treatment of symptomatic BPH

H. Lepor, Grace Machi, 1992, The Prostate.

Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202.

D. Grignon, H. Sandler, H. Lepor, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Informational needs during active surveillance for prostate cancer: A qualitative study.

A. Fagerlin, H. Lepor, H. Carter, 2017, Patient education and counseling.

Nitric oxide synthase in dog urethra: a histochemical and pharmacological analysis

H. Lepor, Masayuki Takeda, 1995, British journal of pharmacology.

Report of a unique meeting between the alpha-blocker subcommittee and the pharmaceutical industry.

H. Lepor, M. Wyllie, J. C. McGrath, 1996, Urology.

α1-Adrenoceptor selectivity and the treatment of benign prostatic hyperplasia and lower urinary tract symptoms

H. Lepor, R. Kirby, K. Andersson, 2000, Prostate Cancer and Prostatic Diseases.

α1‐Adrenoceptor properties of terazosin HCl and its enantiomers in the human prostate and canine brain

H. Lepor, E. Shapiro, R. Tang, 1992, The Prostate.

Binding and functional properties of doxazosin in the human prostate adenoma and canine brain

H. Lepor, E. Shapiro, M. Baumann, 1990, The Prostate.

The mechanism of adverse events associated with terazosin: an analysis of the Veterans Affairs cooperative study.

H. Lepor, W. Williford, K. Jones, 2000, The Journal of urology.

RETROGRADE EJACULATION INDUCED BY SILODOSIN IS THE RESULT OF RELAXATION OF SMOOTH MUSCULATURE IN THE MALE URO-GENITAL TRACTS AND IS ASSOCIATED WITH GREATER URODYNAMIC AND SYMPTOMATIC IMPROVEMENTS IN MEN LUTS SECONDARY TO BPH

C. Roehrborn, H. Lepor, S. Kaplan, 2009 .

Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group.

H. Lepor, 1998, Urology.

Therapeutic controversies: clinical treatment of benign prostatic hyperplasia.

H. Lepor, J. Geller, A. Levine, 1995, The Journal of clinical endocrinology and metabolism.

Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.

T. Branchek, H. Lepor, P. Vaysse, 1998, Journal of medicinal chemistry.

The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.

H. Lepor, S. Meretyk, G. Knapp-Maloney, 1992, The Journal of urology.

Binding and functional properties of endothelin receptor subtypes in the human prostate.

H. Lepor, E. Shapiro, S. Kobayashi, 1994, Molecular pharmacology.

Alpha1−adrenergic blockers in the medical management of benign prostatic hyperplasia

H. Lepor, 1992 .

The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia.

H. Lepor, 2006, Reviews in urology.

The treatment of benign prostatic hyperplasia with alpha1 blockers

H. Lepor, 1994 .

The stereospecificity of LY253352 for α1‐adrenoceptor binding sites in the brain and prostate

H. Lepor, E. Shapiro, M. Baumann, 1988 .

Effects of the Selective α1A‐Adrenoceptor Antagonist Silodosin on ECGs of Healthy Men in a Randomized, Double‐Blind, Placebo‐ and Moxifloxacin‐Controlled Study

H. Lepor, L. Hill, J. Morganroth, 2010, Clinical pharmacology and therapeutics.

New use for alpha blockers: benign prostatic hyperplasia.

H. Lepor, S. L. Lawrence, S. Hill, 1994, American family physician.

Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates.

H. Lepor, A. Nieder, C. O’Connell, 1997, Urology.

Prostate Selectivity of Alpha-Blockers: From Receptor Biology to Clinical Medicine

H. Lepor, 1996 .

Binding and functional properties of alpha1 adrenoceptors in different regions of the human prostate.

H. Lepor, E. Shapiro, S. Meretyk, 1993, The Journal of urology.

Stromal/epithelial interactions of murine prostatic cell lines in vivo: A model for benign prostatic hyperplasia and the effect of doxazosin on tissue size

H. Lepor, E. Shapiro, D. Moscatelli, 2003, The Prostate.

Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder.

T. Sun, S. Taneja, H. Lepor, 1999, The Journal of urology.

Intraoperative frozen section analysis of urethral margin biopsies during radical prostatectomy.

J. Melamed, X. Kong, H. Lepor, 2011, Urology.

The Association of Veterans' PSA Screening Rates with Changes in USPSTF Recommendations.

A. Fagerlin, H. Lepor, D. Makarov, 2020, Journal of the National Cancer Institute.

Open versus robotic radical prostatectomy.

H. Lepor, 2006, Urologic oncology.

Analysis of apical soft tissue margins during radical retropubic prostatectomy.

J. Melamed, H. Lepor, O. Shah, 2001, The Journal of urology.

Open versus laparoscopic radical prostatectomy.

H. Lepor, 2005, Reviews in urology.

Detection of prostate cancer in males with prostatism

H. Lepor, V. Rogenes, E. Kuhn, 1994, The Prostate.

Gleason 6 prostate tumors diagnosed in the PSA era do not demonstrate the capacity for metastatic spread at the time of radical prostatectomy.

Nicholas M. Donin, Ming Zhou, H. Lepor, 2013, Urology.

Para‐anastomotic haematoma volume predicts the presence of anastomotic extravasation after radical retropubic prostatectomy

H. Lepor, S. Telegrafi, R. O'Malley, 2010, BJU International.

The treatment of benign prostatic hyperplasia: a glimpse into the future.

H. Lepor, 1995, Urologic clinics of North America.

Muscarinic cholinergic receptors in the normal and neurogenic human bladder.

H. Lepor, E. Shapiro, M. Baumann, 1989, The Journal of urology.

1640: Development of a Nomogram to Predict Acute Urinary Retention or BPH-Related Surgery with or without Medical Therapy in Men with BPH Based on Data from the MTOPS Trial

M. Kattan, C. Roehrborn, H. Lepor, 2005 .

Total prostate and transition zone volumes, and transition zone index are poorly correlated with objective measures of clinical benign prostatic hyperplasia.

H. Lepor, A. Nieder, C. O’Connell, 1997, The Journal of urology.

Randomized double-blind study comparing the effectiveness of balloon dilation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia.

H. Lepor, G. Machi, D. Sypherd, 1992, The Journal of urology.

Status of radical prostatectomy in 2009: is there medical evidence to justify the robotic approach?

Herbert Lepor, H. Lepor, 2009, Reviews in urology.

Spontaneous renal artery dissection.

H. Lepor, Jamie A. Kanofsky, 2007, Reviews in urology.

Interaction between race and prostate cancer treatment benefit in the Veterans Health Administration

Aisha T. Langford, J. Leppert, A. Fagerlin, 2021, Cancer.

Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate cancer.

D. Grignon, H. Sandler, B. Donnelly, 2010, International journal of radiation oncology, biology, physics.

Long-term continence outcomes in men undergoing radical prostatectomy for clinically localized prostate cancer.

V. Prabhu, H. Lepor, Glen B. Taksler, 2014, European urology.

Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence.

Judith D Goldberg, Herbert Lepor, H. Lepor, 2011, European urology.

Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202.

D. Grignon, H. Sandler, H. Lepor, 2015, International journal of radiation oncology, biology, physics.

Prostate-specific antigen doubling time is a reliable predictor of imageable metastases in men with biochemical recurrence after radical retropubic prostatectomy.

H. Lepor, M. Perlmutter, 2008, Urology.

Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy.

S. Taneja, H. Lepor, R. Thiel, 2005, Urology.

The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.

M. Barry, H. Lepor, W. Williford, 1998, The Journal of urology.

Long-term satisfaction and predictors of use of intracorporeal injections for post-prostatectomy erectile dysfunction.

V. Prabhu, H. Lepor, D. Makarov, 2013, Journal of Urology.

Title Duration of Androgen Deprivation in Locally Advanced Prostate Cancer : Long-Term

D. Grignon, H. Lepor, T. Pisansky, 2017 .

Teaching Hospitals and the Disconnect Between Technology Adoption and Comparative Effectiveness Research: The Case of the Surgical Robot

C. Gross, H. Lepor, D. Makarov, 2017, Medical care research and review : MCRR.

Radical prostatectomy improves and prevents age dependent progression of lower urinary tract symptoms.

V. Prabhu, H. Lepor, D. Makarov, 2014, The Journal of urology.

Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: Application to efficacy assessment of soy protein.

J. Melamed, S. Taneja, H. Lepor, 2001, Urology.

Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer.

Jurgen J Fütterer, Herbert Lepor, J. Fütterer, 2015, European urology.

Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.

T. D. de Reijke, J. Chin, E. Crawford, 2023, European urology.

Radical prostatectomy for long-term functional and oncologic outcomes.

H. Lepor, 2012, European urology.

A continence index predicts the early return of urinary continence after radical retropubic prostatectomy.

R. Shore, H. Lepor, C. Twiss, 2000, The Journal of urology.

Long-term Satisfaction After Open Radical Prostatectomy.

H. Lepor, Ted Lee, Glen B. Taksler, 2015, Urology.

Multiparametric magnetic resonance imaging identifies significant apical prostate cancers

Elton Llukani, A. Rosenkrantz, J. Melamed, 2018, BJU international.

Salvage Cryoablation and Robotic Seminal Vesiculectomy: A Novel Salvage Treatment for Locally Recurrent Prostate Cancer.

S. Taneja, H. Lepor, Michael Smigelski, 2023, Journal of endourology.

10-Year Mortality After Radical Prostatectomy for Localized Prostate Cancer in the Prostate-specific Antigen Screening Era.

Elton Llukani, V. Prabhu, H. Lepor, 2015, Urology.

Muscarinic cholinergic and alpha 2-adrenergic receptors in the epithelium and muscularis of the human ileum.

J. Fleshman, H. Lepor, E. Shapiro, 1990, Surgery.

Penile Rehabilitation Postprostatectomy: Is There a Role for MUSE?

H. Lepor, A. Mccullough, 2008, Reviews in urology.

Combination therapy for non-neurogenic male lower urinary tract symptoms: 1 + 1 does not equal 2.

H. Lepor, 2013, European urology.

Using the 4Kscore Test and Magnetic Resonance Imaging Results to Avoid Unnecessary Prostate Biopsy.

H. Lepor, 2015, Reviews in urology.

Health state utilities among contemporary prostate cancer patients on active surveillance

U. Siebert, A. Fagerlin, H. Lepor, 2018, Translational andrology and urology.

MP48-03 TESTOSTERONE REPLACEMENT THERAPY IN PATIENTS WITH PROSTATE CANCER AFTER PROSTATECTOMY: A 5-YEAR SINGLE CENTER EXPERIENCE

M. Stifelman, S. Taneja, H. Lepor, 2014 .

RADICAL RETROPUBLIC PROSTATECTOMY

H. Lepor, 2001 .

Outcomes of extremely low risk prostate cancer following radical prostatectomy

H. Lepor, J. Laze, E. Lee, 2011, Prostate Cancer and Prostatic Diseases.

A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.

J. Kabalin, H. Lepor, B. Stein, 1995, Urology.

The QT Interval and Selection of Alpha-Blockers for Benign Prostatic Hyperplasia.

H. Lepor, L. Hill, R. Trohman, 2008, Reviews in urology.

Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.

S. Taneja, H. Lepor, D. Penson, 1999, The Journal of urology.

Changes in Penile Morphometrics in Men with Erectile Dysfunction after Nerve-Sparing Radical Retropubic Prostatectomy.

H. Lepor, McCullough, A. Mccullough, 1999, Molecular urology.

The Use of Magnetic Resonance Imaging to Predict Oncological Control Among Candidates for Focal Ablation of Prostate Cancer.

Elton Llukani, J. Melamed, F. Deng, 2017 .

Biopsy Assessment of Oncologic Control 3 Years Following Primary Partial Gland Cryoablation: A Prospective Cohort Study of Men With Intermediate-risk Prostate Cancer

H. Lepor, Rozalba Gogaj, James S. Wysock, 2023, The Journal of urology.

TREATMENT OF BENIGN PROSTATIC HYPERPLASIA. AUTHORS' REPLY

H. Lepor, J. Andersen, V. Nitti, 1996 .

Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System.

H. Lepor, D. Makarov, S. Loeb, 2020, European urology.

394: The Proximal Region of Murine Prostatic Ducts is Enriched in Prostate Stem Cells

H. Lepor, E. Shapiro, D. Moscatelli, 2004 .

10-Year Mortality After Radical Prostatectomy for Localized Prostate Cancer in the Prostate-specific Antigen Screening Era.

Elton Llukani, V. Prabhu, H. Lepor, 2015, Urology.

Identifying quantitative in vivo multi-parametric MRI features for treatment related changes after laser interstitial thermal therapy of prostate cancer

Anant Madabhushi, Robert Toth, Satish Viswanath, 2014, Neurocomputing.

Can contemporary transrectal prostate biopsy accurately select candidates for hemi‐ablative focal therapy of prostate cancer?

S. Taneja, H. Lepor, A. Sankin, 2009, BJU international.

Vascular targeted photodynamic therapy for localized prostate cancer.

H. Lepor, 2008, Reviews in urology.

The binding and functional properties of voltage dependent calcium channel receptors in pediatric normal and myelodysplastic bladders.

H. Lepor, E. Shapiro, R. Tang, 1991, The Journal of urology.

Clinical evaluation of a novel method for the measurement of prostate‐specific antigen, AccuPSATM, as a predictor of 5‐year biochemical recurrence‐free survival after radical prostatectomy: results of a pilot study

Lori J Sokoll, Alan W Partin, Samir S Taneja, 2012, BJU international.

Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature.

H. Lepor, B. Djavan, E. Eckersberger, 2010, The Canadian journal of urology.

Patient centered outcomes in prostate cancer treatment: predictors of satisfaction up to 2 years after open radical retropubic prostatectomy.

H. Lepor, D. Makarov, R. Desai, 2010, The Journal of urology.

Acrolein- and 4-Aminobiphenyl-DNA adducts in human bladder mucosa and tumor tissue and their mutagenicity in human urothelial cells

H. Lepor, M. Tang, W. Huang, 2014, OncoTarget.

A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.

M. Stifelman, A. Rosenkrantz, J. Melamed, 2014, European urology.

Does a nerve‐sparing technique or potency affect continence after open radical retropubic prostatectomy?

H. Lepor, Tracy P. Marien, 2008, BJU international.

Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate.

H. Lepor, J. Engel, Run Wang, 2010, The Journal of urology.

Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902.

Christopher U. Jones, K. Pienta, H. Sandler, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.

H. Lepor, G. Godoy, L. Glickman, 2009, The Journal of urology.

Post-prostatectomy incontinence during sexual activity: a single center prevalence study.

H. Lepor, R. Jain, J. Laze, 2011, The Journal of urology.